DENVER, March 30, 2012 /PRNewswire/ -- MusclePharm Corporation, a Nevada corporation ("MusclePharm" or the "Company") (OTCBB: MSLP.OB), an expanding U.S. nutritional supplement company, is pleased to announce that it has retained PondelWilkinson Inc. as investor relations counsel.
PondelWilkinson will serve as a liaison for MusclePharm to the investment community and financial media, as well as provide counsel for strategic communications. The firm represents a wide range of emerging growth and middle market publicly traded companies.
"PondelWilkinson has more than four decades of investor relations and strategic public relations experience, with particular expertise in the healthcare and nutritional supplements sectors," said John Bluher, chief operating officer of MusclePharm. "Our engagement of PondelWilkinson represents an important step for MusclePharm, as we begin to build new relationships with shareholders and the broader investment community."
ABOUT MUSCLEPHARM CORPORATION
MusclePharm is a healthy life-style company that develops and manufactures a full line of NSF International and Informed Choice approved nutritional supplements that are free of banned substances. Based on years of research at the MusclePharm Sports Science Center, the products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than one hundred elite professional athletes from various professional sports leagues including the National Football League, Mixed Martial Arts and Major League Baseball. The company's products address all categories of an active lifestyle, including muscle building, weight loss and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in more than 120 countries and available in over 10,000 U.S. retail outlets, including GNC and Vitamin Shoppe and Vitamin World. MusclePharm products also are sold through more than 100 online stores, including bodybuilding.com, Amazon.com and Vitacost.com. For more information, please visit www.musclepharm.com
For more information, contact:
Roger Pondel/Robert Jaffe
SOURCE MusclePharm Corporation